DuPont de Nemours Management
Management Kriterienprüfungen 3/4
DuPont de Nemours CEO ist Lori Koch , ernannt in Jun 2024, hat eine Amtszeit von 1.92 Jahren. Die jährliche Gesamtvergütung beträgt $16.13M , bestehend aus 7.7% Gehalt und 92.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.085% der Aktien des Unternehmens, im Wert von $16.49M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.3 Jahre bzw. 6.8 Jahre.
Wichtige Informationen
Lori Koch
Geschäftsführender
US$16.1m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 7.70% |
| Amtszeit als Geschäftsführer | 1.9yrs |
| Eigentum des Geschäftsführers | 0.09% |
| Durchschnittliche Amtszeit des Managements | 1.3yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 6.8yrs |
Jüngste Management Updates
Recent updates
Narrativ-Update • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Seeking Alpha • May 07
DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)
Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking AlphaNarrativ-Update • Apr 23
DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside
Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Narrativ-Update • Apr 08
DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook
Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.Narrativ-Update • Mar 24
DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside
Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Narrativ-Update • Mar 09
DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside
Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.Narrativ-Update • Feb 23
DD: New Guidance And Product Pipeline Will Support Future Upside
Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.Analyseartikel • Feb 17
There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings
The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...Narrativ-Update • Feb 09
DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside
Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).Narrativ-Update • Jan 26
DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity
Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).Narrativ-Update • Jan 12
DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook
Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).Narrativ-Update • Dec 27
DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity
Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.Narrativ-Update • Dec 13
DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook
Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.Narrativ-Update • Nov 29
DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground
Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.Narrativ-Update • Nov 15
DD: Future Share Buybacks Will Unlock Value Amid Uncertainty
Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.Analyseartikel • Nov 09
DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year
DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...Narrativ-Update • Nov 01
DD: Qnity Separation And Water Solutions Will Drive Outperformance
Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.Narrativ-Update • Oct 17
Electronics, Healthcare And Water Will Drive Future Success
Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.Narrativ-Update • Sep 24
Electronics, Healthcare And Water Will Drive Future Success
Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.Narrativ-Update • Sep 04
Electronics, Healthcare And Water Will Drive Future Success
As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.Analyseartikel • Jul 23
Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...Seeking Alpha • Apr 07
DuPont: Upgrading To Hold Amid China Risks
Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking AlphaAnalyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$132m |
| Dec 31 2025 | US$16m | US$1m | US$57m |
| Sep 30 2025 | n/a | n/a | US$479m |
| Jun 30 2025 | n/a | n/a | US$630m |
| Mar 31 2025 | n/a | n/a | -US$234m |
| Dec 31 2024 | US$13m | US$1m | -US$131m |
| Sep 30 2024 | n/a | n/a | US$421m |
| Jun 30 2024 | n/a | n/a | US$260m |
| Mar 31 2024 | n/a | n/a | US$404m |
| Dec 31 2023 | US$4m | US$750k | -US$101m |
| Sep 30 2023 | n/a | n/a | US$895m |
| Jun 30 2023 | n/a | n/a | US$963m |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$5m | US$742k | US$1b |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$960m |
| Mar 31 2022 | n/a | n/a | US$989m |
| Dec 31 2021 | US$5m | US$700k | US$1b |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$1b |
| Mar 31 2021 | n/a | n/a | -US$1b |
| Dec 31 2020 | US$4m | US$647k | -US$1b |
Vergütung im Vergleich zum Markt: LoriDie Gesamtvergütung ($USD16.13M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD14.84M).
Entschädigung vs. Einkommen: LoriDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Lori Koch (50 yo)
1.9yrs
Amtszeit
US$16,134,250
Vergütung
Ms. Lori D. Koch serves as Chief Executive Officer at DuPont Ventures. Ms. Lori is responsible for overseeing the strategic direction of the company to accelerate growth, unlock value, advance innovation,...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$16.13m | 0.085% $ 16.5m | |
| Senior VP & CFO | 1.9yrs | US$4.94m | 0.017% $ 3.3m | |
| Senior VP & General Counsel | no data | US$3.53m | 0.028% $ 5.5m | |
| Chief Human Resources Officer | 5.2yrs | US$2.92m | 0.021% $ 4.1m | |
| President of Healthcare & Water Technologies | less than a year | US$2.25m | 0.0010% $ 197.1k | |
| Chief Operations & Engineering Officer | 1.3yrs | keine Daten | keine Daten | |
| VP of Tax | less than a year | keine Daten | 0.0014% $ 264.8k | |
| Chief Technology Officer | 1.3yrs | keine Daten | keine Daten | |
| SVP, Chief Information Officer & Chief Procurement Officer | less than a year | keine Daten | 0.00046% $ 88.9k | |
| VP of Investor Relations | no data | keine Daten | keine Daten | |
| President of Diversified Industrials | less than a year | keine Daten | keine Daten | |
| Chief Strategy Officer | 1.3yrs | keine Daten | keine Daten |
1.3yrs
Durchschnittliche Betriebszugehörigkeit
51.5yo
Durchschnittliches Alter
Erfahrenes Management: DDDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.3 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$16.13m | 0.085% $ 16.5m | |
| Lead Independent Director | 8.8yrs | US$412.42k | 0.00077% $ 148.8k | |
| Non-Executive Chairman | 8.8yrs | US$7.67m | 0.067% $ 12.9m | |
| Independent Director | 2yrs | US$320.32k | 0.00024% $ 46.4k | |
| Independent Director | 6.9yrs | US$333.22k | 0.00047% $ 90.8k | |
| Independent Director | 6.9yrs | US$340.32k | 0.00024% $ 46.4k | |
| Independent Director | less than a year | keine Daten | 0.00028% $ 54.1k | |
| Independent Director | 1.3yrs | US$393.19k | 0.00024% $ 46.4k | |
| Independent Director | 6.6yrs | US$320.32k | 0.00016% $ 30.9k | |
| Independent Director | 6.9yrs | US$345.32k | 0.00024% $ 46.4k |
6.8yrs
Durchschnittliche Betriebszugehörigkeit
58yo
Durchschnittliches Alter
Erfahrener Vorstand: DDDie Vorstandsmitglieder gelten als erfahren (6.8 Jahre durchschnittliche Amtszeit).
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 11:19 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
DuPont de Nemours, Inc. wird von 38 Analysten beobachtet. 14 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| William Selesky | Argus Research Company |
| Patrick Duffy Fischer | Barclays |
| Michael Leithead | Barclays |